Stocks YPSN
SWXYpsomed Holding (YPSN)
We have not processed filings for Ypsomed Holding yet. This page fills in on its own once we have read them.
What Ypsomed Holding does
Ypsomed Holding develops and manufactures injection and infusion systems for self-medication. Its products include insulin pens, autoinjectors, pen needles, and insulin pump systems. It sells both branded devices to patients and customized delivery systems to pharmaceutical companies. Its shares trade on SWX under the ticker YPSN.
Earnings: every quarter and the next report date
Latest SEC filings
Questions about YPSN
What does Ypsomed Holding do?
Ypsomed Holding develops and manufactures injection and infusion systems for self-medication. Its products include insulin pens, autoinjectors, pen needles, and insulin pump systems. It sells both branded devices to patients and customized delivery systems to pharmaceutical companies. Its shares trade on SWX under the ticker YPSN.
Theses that mention YPSN
- The real bottleneck in the GLP-1 boom is not the molecules, it is glass, stoppers and injector pens Live
Follow YPSN
Get an email when Ypsomed Holding files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Ypsomed Holding tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.